Clinical Trial Update: 2157GCCC:Phase 1 of Calaspargase Pegol-mknl W/ Cytarabine and Idarubicin in Newly Dx AML [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating Calaspargase Pegol-mknl in combination with cytarabine and idarubicin for newly diagnosed acute myeloid leukemia; study status…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• CYTARABINE (CYTARABINE)
• Calaspargase Pegol-mknl (calaspargase pegol-mknl)
• Idarubicin (idarubicin)

Snippet

Sponsor: West Virginia University | Conditions: Acute Myeloid Leukemia | Phase 1 | Status: ACTIVE_NOT_RECRUITING